Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure
NCT ID: NCT01687647
Last Updated: 2014-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
1000 participants
INTERVENTIONAL
2012-09-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
An ancillary study will evaluate the interest of blood predictive biomarkers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation
NCT05440123
Bio Metrology of Nonfibrous Mineral Particles in Bronchoalveolar Lavage Fluids
NCT03917485
EFFECT OF SMOKING ON MUCUS HYPERSECRETION MECHANISMS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
NCT01947218
Exploratory Study of Potential Pulmonary Aspiration Markers From Bronchoalveolar Lavage Fluid
NCT00915941
Aspergillus and Chronic Obstructive Pulmonary Disease Evolution
NCT03646851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Screening
Paired-design: low-dose CT scan, sputum sample and blood test will be performed on all subjects.
low-dose CT-scan AND induced sputum sample AND blood test
All subjects will receive a low-dose CT-scan, a blood test (ancillary study) and provide an induced sputum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low-dose CT-scan AND induced sputum sample AND blood test
All subjects will receive a low-dose CT-scan, a blood test (ancillary study) and provide an induced sputum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent signed
Exclusion Criteria
* Refusal of the study protocol
* Uncontrolled asthma or lung failure
56 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lydia GUITTET, MD,PhD
Role: STUDY_DIRECTOR
Caen University Hospital, INSERM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen University Hospital
Caen, , France
Le Havre Hospital
Le Havre, , France
Rouen University Hospital
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRC11-221
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2011-A01380-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.